Copyright
©The Author(s) 2019.
World J Clin Cases. Jan 26, 2019; 7(2): 137-144
Published online Jan 26, 2019. doi: 10.12998/wjcc.v7.i2.137
Published online Jan 26, 2019. doi: 10.12998/wjcc.v7.i2.137
Variable | Observation group, n = 151 | Control group, n = 678 | t-value | P-value |
ALT, U/L | 35.04 ± 9.18 | 33.22 ± 9.71 | 0.354 | 0.803 |
AST, U/L | 38.96 ± 10.65 | 36.52 ± 10.33 | 0.289 | 0.834 |
TBIL, μmol/L | 11.58 ± 2.87 | 9.99 ± 1.93 | 0.417 | 0.682 |
DBIL, μmol/L | 5.56 ± 0.77 | 4.95 ± 0.64 | 0.392 | 0.786 |
GGT, U/L | 154.56 ± 39.53 | 35.98 ± 8.19 | 35.721 | 0.000 |
ALP, U/L | 171.51 ± 41.74 | 139.49 ± 36.64 | 7.317 | 0.000 |
- Citation: Mei Y, Chen L, Zeng PF, Peng CJ, Wang J, Li WP, Du C, Xiong K, Leng K, Feng CL, Jia JH. Combination of serum gamma-glutamyltransferase and alkaline phosphatase in predicting the diagnosis of asymptomatic choledocholithiasis secondary to cholecystolithiasis. World J Clin Cases 2019; 7(2): 137-144
- URL: https://www.wjgnet.com/2307-8960/full/v7/i2/137.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i2.137